Glucotrack, Inc. Special Meeting of Shareholders

Glucotrack, Inc. (Nasdaq: GCTK) announced a Special Meeting of Shareholders to be held on October 31, 2025, at 12 p.m. ET. Shareholders of record as of September 23, 2025, are entitled to vote on the Equity Purchase Agreement with Sixth Borough Capital Fund. The Board of Directors unanimously recommends voting 'FOR' all proposals. Shareholders are encouraged to vote as soon as possible, either by telephone, online, or by returning their proxy card. Additional details are available in the definitive proxy statement filed with the SEC on October 3, 2025. Glucotrack is a medical technology company focused on developing novel technologies for people with diabetes, including a long-term implantable continuous blood glucose monitoring system.